연구성과로 돌아가기
2024 연구성과별 연구자 정보 (728 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Cohen, S. | Cohen, S | 28 | Tel Aviv Sourasky Med Ctr, Dana Dwek Childrens Hosp, Pediat Gastroenterol Inst, Tel Aviv, Israel | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Garcia Romero, R. | Romero, RG | 29 | Miguel Servet Hosp, Pediat Gastroenterol & Nutr Unit, Zaragoza, Spain | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Dipasquale, V. | Dipasquale, V | 30 | Univ Hosp G Martino, Pediat Gastroenterol & Cyst Fibrosis Unit, Dept Human Pathol Adulthood & Childhood G Barresi, Messina, Italy | ABE-4607-2021 | DIPASQUALE, VALERIA | ||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Uhlig, H. | Uhlig, H | 31 | Univ Oxford, Translat Gastroenterol Unit, Oxford, England | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Uhlig, H. | Uhlig, H | 31 | Univ Oxford, Biomed Res Ctr, Oxford, England | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Uhlig, H. | Uhlig, H | 31 | Univ Oxford, Dept Paediat, Oxford, England | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Shouval, D. | Shouval, D | 32 | Schneider Childrens Med, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel | ||||||
| Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | Shouval, D. | Shouval, D | 32 | Tel Aviv Univ, Fac Med, Tel Aviv, Israel | ||||||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Suh, Chang-Hee | Suh, CH | 1 | Ajou Univ, Sch Med, Dept Rheumatol, Suwon, South Korea | 0000-0001-6156-393X | Suh, Chang-Hee | scbae@hanyang.ac.kr; | |||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Lee, Yoonhee | Lee, YH | 2 | GSK, Med Affairs, Singapore, Singapore | scbae@hanyang.ac.kr; | |||||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Yoo, Sang-Bae | Yoo, SB | 3 | GSK, Med Affairs, Seoul, South Korea | 0000-0002-5210-8182 | Yoo, Sang-Bae | scbae@hanyang.ac.kr; | |||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Quasny, Holly | Quasny, H | 4 | Clin Sci, GSK, Durham, NC USA | 0000-0002-1659-0004 | Quasny, Holly | scbae@hanyang.ac.kr; | |||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Rojas, Aldo Amador Navarro | Rojas, AAN | 5 | GSK, Med Affairs, Singapore, Singapore | scbae@hanyang.ac.kr; | |||||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Hammer, Anne | Hammer, A | 6 | GSK, Immunol Biostat, Collegeville, PA USA | scbae@hanyang.ac.kr; | |||||
| Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | Song, Yeong-Wook | Song, YW | 7 | Seoul Natl Univ Hosp, Div Rheumatol, Seoul, South Korea | 0000-0002-5384-3437 | Song, Yeong Wook | scbae@hanyang.ac.kr; |
페이지 이동: